MedTrace Logo

Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients

NCT06654076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2024-11-12

No results posted yet for this study

Summary

This study aims to assess the diagnostic performance of different tests, including metagenomic next-generation sequencing (mNGS), real-time PCR, galactomannan assay, and lateral-flow device tests, in detecting invasive fungal disease in lung transplant recipients using bronchoalveolar lavage fluid samples. The study is retrospective and cross-sectional in design.

Conditions

  • Invasive Fungal Disease
  • Lung Transplant Recipients
  • Invasive Pulmonary Aspergillosis
  • Pneumocystis Jirovecii Pneumonia

Sponsors & Collaborators

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-04-30
Completion
2024-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06654076 on ClinicalTrials.gov